StonvexLoading…
StonvexStonvexStonvexCore line items from MSTR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $124.30M | $477.23M | $354.25M | $225.55M |
Operating Income | $-14.47B | $-5.44B | $12.00B | $8.11B |
Net Income | $-12.54B | $-3.85B | $8.59B | $10.02B |
EPS (Diluted) | $-38.25 | $-15.23 | $27.71 | $19.43 |
Total Assets | $54.27B | $61.64B | $73.62B | $64.77B |
Total Liabilities | $8.63B | $10.60B | $15.50B | $14.40B |
Cash & Equivalents | $2.21B | $2.30B | $54.28M | $50.09M |
Free Cash Flow OCF − CapEx | $13.04M | $-75.45M | $-53.24M | $-42.13M |
Shares Outstanding | 333.91M | 277.66M | 303.99M | 298.04M |